Streetbeat News

PETV

PetVivo Holdings Inc

Employees

Industry

Surgical and Medical Instrument Manufacturing

petvivo, inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. petvivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. petvivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. petvivo, inc, gel-del technologies, inc. and cosmetalife a corporation are all wholly-owned subsidiaries of petvivo holdings, inc.

Open

0.50

Mkt cap

10M

Volume

1.6K

High

0.55

P/E Ratio

-0.78

52-wk high

1.50

Low

0.50

Div yield

N/A

52-wk low

0.29

Numerous companies are scheduled to report their earnings on February 12, 2024, with expectations spanning from losses to significant profits across various sectors. Key reports include Goodyear Tire & Rubber with expected earnings of $0.36 per share on $5.39 billion revenue, and Avis Budget Group projecting earnings of $4.15 per share on $2.81 billion revenue. The diversity in performance indicators reflects a broad economic landscape, potentially influencing market movements.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 10:21 am

PetVivo Holdings, Inc. announced the release of clinical study results conducted by Inotiv, Inc., demonstrating the safety of Spryng with OsteoCushion Technology for intra-articular injections in cats. The study showed Spryng's excellent safety profile, similar to a benign control, in managing joint-related afflictions in companion animals.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:25 pm

PetVivo Holdings has published the results of a clinical study on the tolerance of dogs to intra-articular injections of Spryng with OsteoCushion Technology. The study is significant for veterinarians and pet owners considering treatment options for canine joint issues.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 1:25 pm

Health care stocks experienced significant movement in Wednesday's intraday session. Kura Oncology (KURA) led the gainers with a 48.1% rise, while Annovis Bio (ANVS) saw the largest drop among the losers, falling 19.2%. Other notable movers included Telesis Bio (TBIO), Ensysce Biosciences (ENSC), and Inhibikase Therapeutics (IKT) with substantial gains, and Sight Sciences (SGHT), Gyre Therapeutics (GYRE), and Curis (CRIS) with notable losses.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 5:31 pm

PetVivo Holdings Inc. has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent titled 'Protein Biomaterials And Biocoacervates And Methods Of Making And Using Thereof'. This notice is a significant step towards the granting of the patent, which can enhance the company's intellectual property portfolio and potentially provide a competitive edge in the market.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:07 pm

PetVivo Holdings has signed a distribution agreement with Covetrus North America for its veterinary medical device, Spryng with OsteoCushion Technology. Covetrus will handle inventory, marketing, and promotion of Spryng across the United States.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 1:03 pm

In Thursday's after-market session, several healthcare stocks experienced significant movements. NuCana, Galecto, Ensysce Biosciences, Atara Biotherapeutics, 60 Degrees, and PetVivo Holdings saw their shares rise, with increases ranging from 7.75% to 15.6%. Conversely, Oncternal Therapeutics, Altamira Therapeutics, Nuwellis, DMK Pharmaceuticals, ASLAN Pharma, and SCWorx saw their shares decline, with decreases ranging from 5.65% to 12.7%. These movements reflect changes in investor sentiment and market dynamics for these small-cap companies.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:31 pm

CarMax, Inc. (NYSE:KMX) shares rose by approximately 8% following its quarterly earnings report, which showed an EPS of $0.52, surpassing the consensus estimate of $0.44, despite a 5.5% year-on-year sales decline. Other stocks experienced significant movements in Thursday's mid-day session, with various companies reporting investments, acquisitions, and regulatory updates that influenced their stock prices.

Portfolio Pulse from Avi Kapoor

December 21, 2023 | 6:01 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. HOOKIPA Pharma (HOOK) saw a 73.2% increase, while HeartBeam (BEAT) rose by 54.23%. PetVivo Holdings (PETV), OneMedNet (ONMD), Anebulo Pharmaceuticals (ANEB), and MeiraGTx Holdings (MGTX) also saw upward movements ranging from 27.89% to 39.02%. On the downside, Clene (CLNN) dropped by 41.5%, Aclarion (ACON) by 28.06%, Panbela Therapeutics (PBLA) by 24.47%, Longeveron (LGVN) by 22.05%, Genetic Technologies (GENE) by 15.37%, and Know Labs (KNW) by 13.51% after their Q4 earnings report was released two days ago.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 5:32 pm

BlackBerry Limited (NYSE:BB) shares dropped over 5% in pre-market trading despite reporting Q3 earnings of 1 cent per share, beating the expected loss of 3 cents per share. The company anticipates Q4 revenue between $150 million to $159 million. Other stocks experienced significant movements in pre-market trading, with Infrared Cameras Holdings Inc. (NASDAQ:MSAI) and Mobile Global Esports Inc. (NASDAQ:MGAM) among the top gainers, while Polished.com Inc. (NYSE:POL) and Nogin, Inc. (NASDAQ:NOGN) were among the biggest losers.

Portfolio Pulse from Avi Kapoor

December 21, 2023 | 12:46 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.